Michael Kishbauch
Director/Board Member at ASTRIA THERAPEUTICS, INC.
Net worth: - $ as of 2024-04-29
Michael Kishbauch active positions
Companies | Position | Start | End |
---|---|---|---|
ASTRIA THERAPEUTICS, INC. | Director/Board Member | 2016-04-04 | - |
Independent Dir/Board Member | 2016-04-04 | - |
Career history of Michael Kishbauch
Former positions of Michael Kishbauch
Companies | Position | Start | End |
---|---|---|---|
ACHILLION PHARMACEUTICALS, INC. | Director/Board Member | 2004-06-30 | 2019-12-31 |
Chief Executive Officer | 2004-06-30 | 2013-08-31 | |
President | 2004-06-30 | 2013-08-31 | |
PROGENICS PHARMACEUTICALS, INC. | Director/Board Member | 2013-08-31 | 2019-10-16 |
Independent Dir/Board Member | 2013-08-31 | 2019-10-16 | |
TETRALOGIC PHARMACEUTICALS CORPORATION | Director/Board Member | 2014-08-31 | 2016-11-30 |
Independent Dir/Board Member | 2014-08-31 | 2016-11-30 | |
ARIAD PHARMACEUTICALS, INC. | Director/Board Member | 2004-08-31 | 2008-11-30 |
OraPharma, Inc.
OraPharma, Inc. Pharmaceuticals: MajorHealth Technology OraPharma, Inc. develops and produces drugs for oral diseases. It offers a suite of products to address a range of patient concerns from the foundation of gums, bone, and teeth to the aesthetics of a whiter smile. The company's products include ARESTIN Microspheres, a locally administered antibiotic indicated as an adjunct to scaling and root planning procedures for the reduction of pocket depth in patients with adult periodontitis; and ONSET Approach, a unique delivery system of locally buffered anesthesia that provides faster onset of anesthesia and a comfortable injection. The company was founded in 1996 and is headquartered in Horsham, PA. | Chief Executive Officer | 1996-08-31 | 2004-06-30 |
Founder | 1996-08-31 | 2004-06-30 | |
President | - | 2004-06-30 | |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Chief Operating Officer | 1991-12-31 | 1994-12-31 |
President | 1991-12-31 | 1994-12-31 | |
Ciba-Geigy Corp. | Corporate Officer/Principal | 1981-12-31 | 1991-12-31 |
Training of Michael Kishbauch
Wesleyan University | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistics
International
United States | 11 |
Operational
Director/Board Member | 5 |
President | 3 |
Independent Dir/Board Member | 3 |
Sectoral
Health Technology | 9 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
TETRALOGIC PHARMACEUTICALS CORPORATION | Health Technology |
ASTRIA THERAPEUTICS, INC. | Health Technology |
Private companies | 6 |
---|---|
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Ciba-Geigy Corp. | Health Technology |
OraPharma, Inc.
OraPharma, Inc. Pharmaceuticals: MajorHealth Technology OraPharma, Inc. develops and produces drugs for oral diseases. It offers a suite of products to address a range of patient concerns from the foundation of gums, bone, and teeth to the aesthetics of a whiter smile. The company's products include ARESTIN Microspheres, a locally administered antibiotic indicated as an adjunct to scaling and root planning procedures for the reduction of pocket depth in patients with adult periodontitis; and ONSET Approach, a unique delivery system of locally buffered anesthesia that provides faster onset of anesthesia and a comfortable injection. The company was founded in 1996 and is headquartered in Horsham, PA. | Health Technology |
Progenics Pharmaceuticals, Inc.
Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
Achillion Pharmaceuticals, Inc.
Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
- Stock Market
- Insiders
- Michael Kishbauch
- Experience